Vicarious Surgical (RBOT) Projected to Post Earnings on Wednesday

Vicarious Surgical (NYSE:RBOT) is expected to release its Q3 2025 results after the market closes on Wednesday, November 12th. Analysts expect the company to announce earnings of ($2.37) per share for the quarter. Interested persons may visit the the company’s upcoming Q3 2025 earningresults page for the latest details on the call scheduled for Wednesday, November 12, 2025 at 4:30 PM ET.

Vicarious Surgical (NYSE:RBOT) last released its quarterly earnings results on Tuesday, August 12th. The company reported ($2.23) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($2.61) by $0.38. On average, analysts expect Vicarious Surgical to post $-11 EPS for the current fiscal year and $-9 EPS for the next fiscal year.

Vicarious Surgical Stock Performance

Vicarious Surgical stock opened at $4.36 on Monday. Vicarious Surgical has a 52 week low of $4.23 and a 52 week high of $19.00. The firm has a market capitalization of $25.96 million, a price-to-earnings ratio of -0.43 and a beta of 1.41. The company has a 50 day moving average price of $5.80 and a 200 day moving average price of $7.33.

Analyst Ratings Changes

A number of research firms have recently issued reports on RBOT. Weiss Ratings restated a “sell (e+)” rating on shares of Vicarious Surgical in a report on Wednesday, October 8th. Wall Street Zen raised Vicarious Surgical to a “sell” rating in a research note on Saturday, September 13th. Finally, Piper Sandler decreased their price objective on Vicarious Surgical from $8.50 to $7.00 and set a “neutral” rating for the company in a research report on Wednesday, August 13th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Reduce” and an average target price of $7.00.

About Vicarious Surgical

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.